文献速递主动脉疾病

胸腹主动脉瘤范围与复杂腔内修复术后死亡率的关联

Association between thoracoabdominal aneurysm extent and mortality after complex endovascular repair.
PubMed 文献 · J Vasc Surg · 2020-10-22

基于VQI注册数据的回顾性队列研究,纳入2010至2019年2062例无症状退行性胸腹主动脉瘤腔内修复患者,按Crawford范围分组。结果显示范围I-III组1年死亡率最高(18.4%),范围IV-V组最低(7.8%),范围0组为8.4%;Crawford范围I-III是死亡的独立术前预测因素。

要点

  • 胸腹主动脉瘤范围越广,腔内修复术后1年及长期生存越差。
  • 术前COPD、慢性肾病和年龄也是死亡的独立预测因素。

核心结论

  • 与开放手术类似,累及范围更广的主动脉疾病患者接受腔内修复术后1年及长期生存更差。
  • 主动脉疾病范围和预期术后生存应重点纳入择期腔内胸腹主动脉瘤修复的手术决策。

研究设计与样本

  • 回顾性队列研究,数据来自血管外科学会血管质量倡议(VQI)胸主动脉及复杂腔内动脉瘤修复注册库。
  • 纳入2010至2019年因无症状退行性动脉瘤接受治疗的患者,共2062例符合标准。
  • Crawford范围I至V根据注册库记录的近端和远端锚定区定义,未累及内脏主动脉者分为0a或0b。
  • 采用Kaplan-Meier法估计生存率,Cox比例风险回归模型识别死亡预测因素。

主要发现

  • Crawford范围分布:0a 379例,0b 848例,I 81例,II 98例,III 130例,IV 454例,V 72例。
  • 根据初步分析结果将患者分为三组:范围0a和0b组、范围I-III组、范围IV-V组。
  • 范围0a和0b组平均生存时间70.7±1.43个月,范围I-III组48.6±1.65个月,范围IV-V组57.6±1.24个月。
  • 三组对应的1年死亡率分别为8.4%、18.4%和7.8%。

临床怎么用

  • 在择期腔内胸腹主动脉瘤修复术前评估中,应将动脉瘤范围作为生存预测的重要依据。
  • 对于Crawford范围I-III的患者,需权衡手术获益与较差的1年及长期生存。
  • 合并COPD、慢性肾病或高龄患者,应个体化评估手术风险。

局限性

  • 回顾性队列设计,存在选择偏倚和未测量混杂因素的可能。
  • 数据来源于注册库,Crawford范围根据锚定区定义,可能与解剖学范围存在差异。
  • 原文未报告术后并发症的具体类型及其与死亡率的关联细节。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Traditional open surgical repair of thoracoabdominal aortic aneurysms (TAAAs) has historically resulted in 30-day mortality rates ranging from 6% to 20%, depending on the Crawford anatomic extent. Although short-term survival is important, long-term survival is essential for patients to benefit from these often elective and potentially morbid procedures. The aneurysm extent affects the long-term survival after open repair; however, effect on endovascular repair is unknown and could influence the decision process for repair. We evaluated the association between aneurysm extent and survival and identified patient and perioperative factors associated with mortality after endovascular repair. METHODS: A retrospective cohort of patients treated for TAAAs recorded in the Society for Vascular Surgery Vascular Quality Initiative thoracic and complex endovascular aneurysm repair registry were evaluated. All patients treated for asymptomatic degenerative aneurysms from 2010 to 2019 were included. Crawford extent I to V was defined according to the proximal and distal landing zones documented in the registry. Patients without extension into the visceral aorta were used for comparison and categorized as having extent 0a or 0b, depending on the distal landing zone in the thoracic aorta. Kaplan-Meier plots were used to estimate survival, and Cox proportional hazard regression models were created to identify the predictors of mortality. RESULTS: From 2010 to 2019, 15,333 patients were entered into the registry, of whom 2062 met the inclusion criteria. The Crawford extent was 0a for 379, 0b for 848, I for 81, II for 98, III for 130, IV for 454, and V for 72. Three groups were created in accordance with the similar outcomes noted on a preliminary analysis: (1) extent 0a and 0b; (2) extent I, II, and III; and (3) extent IV and V. The mean survival time for the extent 0a and 0b group was 70.7 ± 1.43 months and was 48.6 ± 1.65 months for the extent I, II, and III group and 57.6 ± 1.24 months for the extent IV and V group. The corresponding 1-year mortality was 8.4%, 18.4%, and 7.8%. Cox regression analysis identified the following preoperative factors were associated with mortality: chronic obstructive pulmonary disease (odds ratio [OR], 1.70; P < .001), Crawford extent I to III (OR, 1.64; P = .015), preexisting chronic kidney disease (OR, 1.37; P = .024), and age per year (OR, 1.03; P < .001). A number of postoperative factors were also associated with mortality. CONCLUSIONS: Similar to open TAAA repair, patients with more extensive aortic disease treated with endovascular repair had worse 1-year and long-term survival. The extent of aortic disease and anticipated postoperative survival should factor prominently into the surgical decision-making process for elective endovascular TAAA repair.

来源:J Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Heslin RT, Sutzko DC, Axley J, et al. Association between thoracoabdominal aneurysm extent and mortality after complex endovascular repair. J Vasc Surg. 2020. PMID: 33098946. doi:10.1016/j.jvs.2020.10.025

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。